Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development

•The TB vaccine development pipeline moves slowly and includes few candidates.•TB progression-associated candidate antigens have recently been identified.•Investigation to identify vaccine-induced correlates of protection against TB is underway.•The mRNA platform may accelerate screening and manufac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2023-11, Vol.41 (48), p.7060-7066
Hauptverfasser:	Looney, Monika M., Hatherill, Mark, Musvosvi, Munyaradzi, Flynn, JoAnne, Kagina, Benjamin M, Frick, Mike, Kafuko, Zacharia, Schmidt, Alex, Southern, James, Wilder-Smith, Annelies, Tippoo, Patrick, Paradkar, Vikram, Popadić, Dušan, Scriba, Thomas J., Hanekom, Willem, Giersing, Brigitte
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Antigens bacteria Capacity development COVID-19 vaccines Development strategies Disease prevention Disease transmission ethics Fatalities Global health Humans Immunization Immunology industry Infections Infectious diseases Low income groups mRNA Mycobacterium tuberculosis Mycobacterium tuberculosis - genetics Pandemics people Public health R&D Research & development RNA, Messenger - genetics Social sciences Technology transfer Teenagers Tuberculosis Tuberculosis Vaccines - genetics Vaccine development Vaccines World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!